Silvercrest Asset Management Group »

Tvardi Therapeutics shares owned by Silvercrest Asset Management Group

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Silvercrest Asset Management Group from 13F filings

Historical chart of Silvercrest Asset Management Group investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Silvercrest Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Silvercrest Asset Management Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $872k 22k 38.97

More positions owned by Silvercrest Asset Management Group

Microsoft Corporation (MSFT)
Broadcom (AVGO)
Apple (AAPL)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Rus 1000 Grw Etf (IWF)
Abbott Laboratories (ABT)
Oracle Corporation (ORCL)
Cadence Bank (CADE)
Glacier Ban (GBCI)
Home Depot (HD)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Williams Companies (WMB)
Cisco Systems (CSCO)
Atmos Energy Corporation (ATO)
Alphabet Inc Class A cs (GOOGL)

View all positions for Silvercrest Asset Management Group

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
683 Capital Management
Vestal Point Capital
Geode Capital Management
Invesco
FMR
Parkman Healthcare Partners
State Street Corporation
UBS Group
Farallon Capital Management
Northern Trust
Renaissance Technologies
Boothbay Fund Management

View all funds holding Tvardi Therapeutics